More on BLRX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.71 |
|
|||
| Open | $2.70 | ||||
| 52 Wk High | $1.63 | ||||
| 52 Wk Low | $0.71 | ||||
| Day High | $2.73 | ||||
| Day Low | $2.56 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 9,538 | ||||
- Form 6-K BioLineRx Ltd. For: Feb 23
- Form S-8 BioLineRx Ltd.
- Form 6-K BioLineRx Ltd. For: Nov 24
- BioLineRx (BLRX) Tops Q3 EPS by 8c
- BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
- Hemispherian receives USPTO patent allowance for GLIX1 cancer treatment
- Hemispherian Announces USPTO Notice of Allowance for Key GLIX1 Patent Covering Majority of Solid Tumors
- BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
- Form 6-K BioLineRx Ltd. For: Nov 17
- BioLineRx receives patent allowance for GLIX1 cancer treatment
Entities mentioned with BLRX
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- H.C. Wainwright | View Related Stories »
- PDUFA | View Related Stories »
- Roth Capital | View Related Stories »
- Show More...
